For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Get your A into G: Assess renal and cardiovascular risk
Get your A into G: Assess renal and cardiovascular risk

We are on our summer break and the editorial office is closed until 13 January. In the meantime, please enjoy our Summer Hiatus series, in which our journalists curate an eclectic mix from our news and clinical archives throughout the year, The Conversation and other publications we share content with. Please note the comment function has been turned off while we are away. Happy reading!
This article was first published online on 14 August 2024.
Pharmacist prescriber Leanne Te Karu highlights the importance of diagnosing chronic kidney disease early, which involves incorporating renal screening into cardiovascular risk assessments
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
1. Walker C, Reid S, White C, et al. Management of chronic kidney disease for Māori in Aotearoa, New Zealand: a summary of clinical practice guidelines. N Z Med J 2024;137(1594):62–68.
2. Ortiz A, Wanner C, Gansevoort R. Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association. Nephrol Dial Transplant 2023;38(3):527–31.
3. Mayne KJ, Hanlon P, Lees JS. Detecting and managing the patient with chronic kidney disease in primary care: A review of the latest guidelines. Diabetes Obes Metab 2024; 3 May online.
4. Palmer SC, Craig JC, Navaneethan SD, et al. Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med 2012;157(4):263–75.
5. London Kidney Network. CKD in Primary Care: new approaches to reduce inequalities and save lives. September 2022.